Objective: Controversy persists with regard to the treatment of patients with aortic atresia. Staged reconstructive operations and primary transplantation have been advocated as treatment strategies, but in many instances no treatment is undertaken. A multi-institutional study was undertaken fi~r the purpose of characterizing this challenging patient group, comparing the prevalence and outcomes of the various treatment strategies, and identifying potential predictors of success or failure with each. Methods and results: A total of 323 neonates with aortic atresia were entered into a 21-institution prospective, nonrandomized study between January 1, 1994, and January 1, 1997. Three protocols were used, nonexclusively in many institutions: (1) staged reconstructive surgery with initial palliation by a Norwood procedure and eventual Fontan operation, (2) heart transplantation as initial definitive therapy, and (3) nonsurgical management. Analysis was based on initial protocol assignment: staged reconstructive surgery in 253 patients, heart transplantation in 49 patients, and nonsurgical management in 21 patients. For all patients initially entered into the 2 surgical treatment protocols, survival at 1, 3, 12, 24, and 36 months after entry was 67%, 59%, 52%, 51%, and 50%, respectively. A multivariable analysis found incremental risk factors for death at any time after entry to be lower birth weight (P = .04), associated noncardiac anomaly (P = .007), and entry into the nonsurgical protocol (P < .0001) or the staged reconstructive surgery protocol (P = .03). Four institutions had higher survival statistics; 2 used a heart transplantation protocol and 2 used a staged reconstructive surgery protocol. For the 113 patients treated at these 4 institutions, survival at 1, 3, 12, 24, and 36 months after entry was 77%, 70%, 64%, 62%, and 61%, respectively. Survival among the 4 institutions was similar (P = 0.1). Conclusions: Among patients with aortic atresia, other features of cardiac structure including aortic size, degree of left ventricular hypoplasia, and degree of mitral hypoplasia or atresia are not predictive of survival from 2 surgical protocols. The highest survival was achieved with either treatment strategy at institutions strongly committed to the use of one or the other surgical management protocol. (J Thorac Cardiovasc Surg 1998;116:417-31) From the Division
A ortic valve atresia is the anatomic hallmark of the largest group of neonates born with a cardiac malformation with single ventricle physiology. Of all babies considered to have hypoplastic left heart syndrome, two thirds or more have aortic valve atresiaJ' 2 In the absence of specific therapy, physiologic constriction of the ductus arteriosus after birth leads invariably to death from systemic hypoperfusion, coronary insufficiency, or congestive heart failure. Treatment strategies have evolved on the basis of either reconstructive surgery, along the lines developed by Norwood and others, 3' 4 or cardiac replacement, as pioneered by Bailey and others.S, 6 There have been numerous reports of encouraging and improving outcomes with one or the other treatment strategy from several institutions. 7-9 Nonetheless, the relative efficacy of these 2 treatment strategies remains a matter of speculation, and in many instances babies with aortic atresia are allowed to die of the predictable natural history of the disease without therapeutic intervention.
A study of outcomes in a large group of neonates with aortic atresia could be of value to perinatologists, neonatologists, pediatric cardiologists and surgeons, and others involved in the support and management of families with fetuses and neonates with aortic atresia. A multi-institutional study was begun to provide such information. Analysis is centered around the intention to treat (or not treat) with a protocol based on (1) staged reconstructive surgery (Norwood procedure followed ultimately by Fontan-type reconstruction), (2) heart transplantation as initial definitive therapy, or (3) no surgical treatment. Among the goals of the study were to define the spectrum of cardiac morphology associated with aortic valve atresia, to define the spectrum of surgical approaches currently used and their respective outcomes, and to undertake analyses leading to inferences concerning the impact of patient characteristics and treatment strategies on outcome. In this initial report of the Congenital Heart Surgeons Society Multi-Institutional Study, analysis is strictly limited to those patients with aortic valve atresia (a database has been simultaneously, generated for patients with aortic valve stenosis and associated left heart obstructive lesions), and consideration of outcomes is limited to determination of intermediate-term survival.
Patients and methods
Patients. Between January 1, 1994, and January 1, 1997, 323 neonates (age < 30 days) with aortic valve atresia were entered into a prospective study in 21 institutions (Appendix A). Two thirds of the patients were aged 2 days or less at admission and 90% were aged 7 days or less. The diagnosis of aortic valve atresia was made in all instances by 2-dimensional echocardiography. Follow-up. The physician, family, or guardian of each patient not known to be dead was contacted each year since the beginning of the study. The most recent fol- mean follow-up time for survivors is 21 + 9.6 months (standard deviation). Morphology. Estimates of left ventricular size and of the structure and patency of the mitral valve were obtained from echocardiographic reports from the participating institutions. Information regarding associated cardiac anomalies and size of the ascending aorta were obtained from echocardiographic and operative reports.
Protocols. Each patient was entered into 1 of 3 protocols based on initial intention to treat at the participating institution. Thus all patients listed for heart transplantation were considered to have entered the heart transplantation protocol. All patients managed with intent to perform an initial palliative reconstructive operation were considered to have entered the staged reconstructive surgery protocol. Patients who entered into neither surgical treatment protocol were considered to have entered a protocol of nonsurgical management. Analysis was undertaken in relation to intention to treat (initial protocol assignment). Inasmuch as there were a few instances of crossover (from nonsurgical management to either of the treatment protocols or from one surgical treatment protocol to the other), analysis was subsequently undertaken with respect to the event of either Norwood procedure or heart transplant operation.
Data collection and analyses. Copies of all hospital documents were sent to the Data and Analysis Center at the University of Alabama at Birmingham. The data were abstracted into computer files, and these and the copies of the hospital documents were retained in confidential storage. Numerous tabulations, contingency tables, and life table analyses (Kaptan-Meier method) were made. Timc-related freedom from death or other outcome events, and the hazard function, were also computed parametrically. Numerous multivariable analyses were made in the time-related hazard function regression domain1°; other regression models were used when indi- cated. All continuous variables were examined as continuous variables (not polytomized). Interaction terms were sought in all multivariable analyses: in equations of this paper, these may be thought of as terms (variables) that are active or inactive only in certain specified relations with other variables. Variables with a P value < .1 were retained in the final equation. Variables used in the multivariable analyses and incremental risk factors for death at any time after entry are listed in Appendix B.
To estimate the proportion of neonates entering each of the two surgical protocols that will achieve definitive repair, a Competing Risks of Events Analysis was performed. 11 The mutually exclusive definitive states after entry into the staged reconstructive surgery protocol were as follows: Fontan operation, 2-ventricle repair, crossover to heart transplantation, and death before definitive repair. Those for the heart transplantation protocol were heart transplantation, crossover to a Norwood operation, and death while awaiting transplantation.
Results

Morphology.
Of the 323 patients with aortic valve atresia, 309 patients (96%) had severe left ventricular hypoplasia. Of these, 175 patients had mitral atresia, 117 had a patent but stenotic or hypoplastic mitral valve, and 17 patients had unknown mitral valve morphology. Six patients (2%) had a moderate degree of left ventricular hypoplasia, and 8 patients (2.5%) had a normal-sized left ventricle. Of these 8 patients, all but 1 had a nonrestrictive ventricular septal defect. In total, there were 13 patients (4%) with ventricular septal defects of various sizes. The spectrum of cardiac anomalies associated with aortic valve atresia is shown in Table I and associated noncardiac anomalies in Table II . Interval (Months) After Entry Survival. For all 323 patients, survival at 1, 3, 12, 24, and 36 months after entry was 63%, 55%, 50%, 48%, and 47%, respectively (Fig. 1, A) . The single phase of hazard was a rapidly declining one, but an appreciable instantaneous risk of death was still present 12 months after entry (Fig. 1, B) . As stated, numerous patient factors, protocol or procedure factors, and experience factors were used in multivariable analyses to identify risk factors for (correlates of) death at any time after entry. Among demographic and morphologic factors, those identified as risk factors for death at any time after entry include lower birth weight (/9 = .04), nonwhite race (P -.02), and the presence of an associated noncardiac anomaly (P = .007). None of the features of cardiac morphology analyzed, including ascending aortic size, degree of left ventricular hypoplasia, and degree of mitral hypoplasia or atresia, were predictive of survival° Of the 21 participating institutions, 9 institutions entered patients into more than 1 protocol, including 4 institutions that used both surgical treatment protocols (Table ITI) . A total of 253 patients (78%) were entered into a staged reconstructive surgery protocol, 49 patients (16%) into a heart transplantation protocol, and 21 patients (7%) into a nonsurgical protocol. There were a total of 10 crossovers, including 3 patients from the nonsurgical protocol into either the staged reconstructive surgery (n = 2) or transplantation (n --1) protocol. All 3 of these patients were alive at most recent follow-up. Fig. 2 depicts schematically the fate of the 323 patients after initial protocol assignment.
In comparing protocols, the likelihood of death at any time after entry was higher for patients in the no treatment protocol (P < .0001) or the staged reconstructive surgery protocol (P = .03) than for those in the transplantation protocol. Four institutions were Jacobs el al. Interval (Months) After Entry Fig. 6 . Non-risk-adjusted survival and hazard function for death for patients (n = 49) initially entered in the heart transplant protocol. A, Survival after entry (at time zero). B, Hazard function for death.
identified as having higher survival than the rest (lower risk of death at any time after entry), P < .05. Two of these institutions used the staged reconstructive surgery protocol and 2 the heart transplantation protocol. For the 113 patients treated at these 4
institutions, survival at 1, 3, 12, 24, and 37 months after entry was 77%, 70%, 64%, 62%, and 61%, respectively (Fig. 3) . protocol were distributed among 19 different institutions, with 3 institutions accounting for 140 (55%) of the patients and with half of the institutions each accounting for 5 patients or fewer. Time-related survival among the 253 patients entered into the staged reconstructive surgery protocol is depicted in Fig. 4 , A. The hazard function for death has only a single declining phase with a sharp change in the rate of decline (inflection) at about 4 months after entry (Fig. 4, B) . For patients entered into the staged reconstructive surgery protocol, incremental risk factors for death at any time after entry (multivariable analysis) include lower birth weight and associated noncardiac anomalies. More recent date of entry tended to be associated with a higher risk of mortality (P = .09). Two institutions were identified as negative risk factors for death at any time after entry. However at each of these 2 low-risk institutions, more recent date of admission was associated with a higher risk of mortality (P < .05).
Of patients managed initially with a first-stage Norwood procedure, 121 patients have subsequently undergone a superior vena cava-pulmonary artery anastomosis (bidirectional Glenn or hemi-Fontan procedure) at a median age of 6.4 months. Thirtyeight have thus far undergone a completion Fontan operation at a median age of 20 months. Fig. 5 depicts a Competing Risks Analysis of the various events after initial enrollment in the staged reconstructive surgery protocol.
Transplantation protocol. The 49 patients entered into a heart transplantation protocol were distributed among 6 different institutions, with 3 institutions accounting for 45 (92%) of the patients. Time-related survival among the 49 patients entered into a heart transplantation protocol is depicted in Fig. 6 , A. The hazard function for death has only a single declining phase with a change in the rate of decline (inflection) at 4 to 5 months (Fig. 6, B) . For patients entered into the heart transplantation protocol, incremental risk factors for death at any time after entry included lower birth weight and nonwhite race. Of the 3 institutions accounting for most of the patients in the heart transplantation protocol, 2 were identified as having higher survivals for patients in the heart transplantation protocol than the others. These 2 centers together accounted for 34 pa- tients in the heart transplantation protocol and for 5 patients in the nonsurgical protocol. Of the total of 49 patients initially entered into the heart transplantation protocol, 36 underwent heart transplantation. Four patients crossed over to reconstructive surgery and underwent a first-stage Norwood procedure (with 2 survivors) and 1 was removed from the transplant list and died. Eight others died awaiting transplantation. Fig. 7 depicts a Competing Risks Analysis of the various events after initial enrollment in the heart transplantation protocol. That the altered natural history of patients receiving supportive care in anticipation of eventual transplantation is markedly different from the natural history of the disease itself is illustrated in Fig. 8 , depicting non-risk-adjusted survival of patients awaiting transplantation and of those in the nonsurgical treatment protocol.
Protocol comparisons. Non-risk-adjusted survival at any time after entlT was higher for patients in the heart transplantation protocol than for those in the staged reconstructive surgery protocol (Fig.  9) . Time-related survival was by far lowest in the nonsurgical protocol, with all survival accounted for by protocol crossovers.
Each of the 4 low-risk institutions made virtually exclusive use of one or the other of the 2 surgical treatment protocols. Three of the 4 institutions also entered a total of 5 patients into a nonsurgical treatment protocol. To characterize the outcome of surgical treatment at a low-risk institution, and to determine whether an optimal treatment protocol could be identified, the survival of patients managed in the respective surgical treatment protocols at these 4 institutions was compared ( Fig. 10, A) . Despite the use of the 2 different surgical protocols, the difference in survival statistics among the 4 institutions was not more than could be due to chance alone (P -.1 ), with 70% confidence limits converging at an interval of approximately 1 week after entry. Survival at 1, 3, 12, 24, and 36 months after entry was 77%, 70%, 64%, 62%, and 62%, respectively, for patients treated at the 4 tow-risk institutions. These results using the 2 treatment protocols at the 4 low-risk institutions are also compared with corresponding results at the remainder of the institutions (Fig. 10, B) .
Discussion
Critique of the study. This study has the advantage of having enrolled 323 neonates with a single diagnosis in 3 years (enrollment and annual follow-up continue). Most of the previous studies Interval (Months) After Entry originating from individual institutions report the results of treatment of considerably smaller patient groups. Among those institutions having reported on experience with large volumes of patients, virtually all have contributed to this multi-institutional study. 12-16 The majority of previous reports focus on the outcome of a particular operative strategy (ie, either the Norwood operation or orthotopic heart transplantation) and, in most instances, are reflective of the management of a heterogeneous patient group in that they describe the management and outcomes of patients with hypoplastic left heart syndrome or lesions resembling this syndrome. By limiting the analysis to those patients with aortic valve atresia, we have hoped to shed light on the influence of treatment strategy on a more anatomically and physiologically homogeneous patient population. Nevertheless, the study has limitations. No attempt was made to prospectively randomize management protocols. As such, the selection of protocols and therefore the inferences that can be made concerning results may to some extent still be influenced by individual institutional biases. Study design did not enable us to ascertain whether there are anatomic, morphologic, or other patient characteristics which for this specific cardiac anomaly would mitigate for a higher likelihood of survival with one or the other of the surgical treatment strategies. It has been speculated, for example, that this may be true with regard to either severe tricuspid valve incompetence or pulmonary venous obstruction resulting from intact atrial septum or anomalies of pulmonary venous return. Although these last 2 were among the associated cardiac anomalies included in the multivariable analyses, their relatively low prevalence together with the overall mortality of approximately 50% may have led to an underestimate of their potential importance.
The study is also limited by our current inability to identify and analyze any late-phase events associated with either of the treatment strategies. Certainly a consideration of the late-phase events after 
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